Yasuko Kureishi Bando

Yasuko Kureishi Bando

Auto-generated profile, based on publicly available information

Yasuko Kureishi Bando

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2000 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
YKYasuko Kureishi
Yasuko Kureishi
ZLZhengyu Luo
Zhengyu Luo
ISIchiro Shiojima
Ichiro Shiojima
ABAnn Bialik
Ann Bialik
DFDavid Fulton
David Fulton
KWKenneth Walsh
Kenneth Walsh

1 May 1997 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
YKYasuko Kureishi
Yasuko Kureishi
SKSei Kobayashi
Sei Kobayashi
MAMutsuki Amano
Mutsuki Amano
KKKazushi Kimura
Kazushi Kimura
HKHideo Kanaide
Hideo Kanaide
MIMasaaki Ito
Masaaki Ito
Small GTPase Rho plays pivotal roles in the Ca2+ sensitization of smooth muscle. However, the GTP-bound active form of Rho failed to exert Ca2+-sensitizing effects in extensively Triton X-100-permeabilized smooth muscle preparations, due to the loss of the important diffusible cofactor (Gong, M. C., Iizuka, K., Nixon, G., Browne, J. P., Hall, A., Eccleston, J. F., Sugai, M., Kobayashi, S., Somlyo, A. V., and Somlyo, A. P. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 1340–1345). Here we demonstrate the contractile effects of Rho-associated kinase (Rho-kinase), recently identified as a putative target of Rho, on the Triton X-100-permeabilized smooth muscle of rabbit portal vein. Introduction of the constitutively active form of Rho-kinase into the cytosol of Triton X-100-permeabilized smooth muscle provoked a contraction and a proportional increase in levels of monophosphorylation of myosin light chain in both the presence and the absence of cytosolic Ca2+. These effects of constitutively active Rho-kinase were wortmannin (a potent myosin light chain kinase inhibitor)-insensitive. Immunoblot analysis revealed that the amount of native Rho-kinase was markedly lower in Triton X-100-permeabilized tissue than in intact tissue. Our results demonstrate that Rho-kinase directly modulates smooth muscle contraction through myosin light chain phosphorylation, independently of the Ca2+-calmodulin-dependent myosin light chain kinase pathway.

7 March 2003 in Circulation Research
Verified
Journal Article
Closed access
PDF file
TSTetsuya Seko
Tetsuya Seko
MIMasaaki Ito
Masaaki Ito
YKYasuko Kureishi
Yasuko Kureishi
RORyuji Okamoto
Ryuji Okamoto
NMNobuyuki Moriki
Nobuyuki Moriki
TNTakeshi Nakano
Takeshi Nakano
Two mechanisms are proposed to account for the inhibition of myosin phosphatase (MP) involved in Ca 2+ sensitization of vascular muscle, ie, phosphorylation of either MYPT1, a target subunit of MP or CPI-17, an inhibitory phosphoprotein. In cultured vascular aorta smooth muscle cells (VSMCs), stimulation with angiotensin II activated RhoA, and this was blocked by pretreatment with 8-bromo-cGMP. VSMCs stimulated by angiotensin II, endothelin-1, or U-46619 significantly increased the phosphorylation levels of both MYPT1 (at Thr696) and CPI-17 (at Thr38). The angiotensin II-induced phosphorylation of MYPT1 was completely blocked by 8-bromo-cGMP or Y-27632 (a Rho-kinase inhibitor), but not by GF109203X (a PKC inhibitor). In contrast, phosphorylation of CPI-17 was inhibited only by GF109203X. Y-27632 dramatically corrected the hypertension in N ω -nitro- l -arginine methyl ester (L-NAME)-treated rats, and this hypertension also was sensitive to isosorbide mononitrate. The level of the active form of RhoA was significantly higher in aortas from L-NAME-treated rats. Expression of RhoA, Rho-kinase, MYPT1, CPI-17, and myosin light chain kinase were not significantly different in aortas from L-NAME-treated and control rats. Activation of RhoA without changes in levels of other signaling molecules were observed in three other rat models of hypertension, ie, stroke-prone spontaneously hypertensive rats, renal hypertensive rats, and DOCA-salt rats. These results suggest that independent of the cause of hypertension, a common point in downstream signaling and a critical component of hypertension is activation of RhoA and subsequent activation of Rho-kinase.

1 February 1999 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JFJianhua Feng
Jianhua Feng
MIMasaaki Ito
Masaaki Ito
YKYasuko Kureishi
Yasuko Kureishi
KIKazuhito Ichikawa
Kazuhito Ichikawa
MAMutsuki Amano
Mutsuki Amano
TNTakeshi Nakano
Takeshi Nakano
Rho-associated kinase (Rho-kinase) from chicken gizzard smooth muscle was purified to apparent homogeneity (160 kDa on SDS-polyacrylamide gel electrophoresis) and identified as the ROKα isoform. Several substrates were phosphorylated. Rates with myosin phosphatase target subunit 1 (MYPT1), myosin, and the 20-kDa myosin light chain were higher than other substrates. Thiophosphorylation of MYPT1 inhibited myosin phosphatase activity. Phosphorylation of myosin at serine 19 increased actin-activated Mg+-ATPase activity, i.e. similar to myosin light chain kinase. Myosin phosphorylation was increased at higher ionic strengths, possibly by formation of 6 S myosin. Phosphorylation of the isolated light chain and myosin phosphatase was decreased by increasing ionic strength. Rho-kinase was stimulated 1.5–2-fold by guanosine 5′-O-3-(thio)triphosphate·RhoA, whereas limited tryptic hydrolysis caused a 5–6-fold activation, independent of RhoA. Several kinase inhibitors were screened and most effective were Y-27632, staurosporine, and H-89. Several lipids caused slight activation of Rho-kinase, but arachidonic acid (30–50 μm) induced a 5–6-fold activation, independent of RhoA. These results suggest that Rho-kinase of smooth muscle may be involved in the contractile process via phosphorylation of MYPT1 and myosin. Activation by arachidonic acid presents a possible regulatory mechanism for Rho-kinase.

1 August 2001 in Journal of Biological Chemistry
Verified
Journal Article
Open access
JGJean-Philippe Gratton
Jean-Philippe Gratton
Manuel Morales-RuizManuel Morales-Ruiz
Manuel Morales-Ruiz
YKYasuko Kureishi
Yasuko Kureishi
DFDavid Fulton
David Fulton
KWKenneth Walsh
Kenneth Walsh
WSWilliam C. Sessa
William C. Sessa
Vascular endothelial growth factor (VEGF) utilizes a phosphoinositide 3-kinase (PI 3-kinase)/Akt signaling pathway to protect endothelial cells from apoptotic death. Here we show that PI 3-kinase/Akt signaling promotes endothelial cell survival by inhibiting p38 mitogen-activated protein kinase (MAPK)-dependent apoptosis. Blockade of the PI 3-kinase or Akt pathways in conjunction with serum withdrawal stimulates p38-dependent apoptosis. Blockade of PI 3-kinase/Akt also led to enhanced VEGF activation of p38 and apoptosis. In this context, the pro-apoptotic effect of VEGF is attenuated by the p38 MAPK inhibitor SB203580. VEGF stimulation of endothelial cells or infection with an adenovirus expressing constitutively active Akt causes MEKK3 phosphorylation, which is associated with decreased MEKK3 kinase activity and down-regulation of MKK3/6 and p38 MAPK activation. Conversely, activation-deficient Akt decreases VEGF-stimulated MEKK3 phosphorylation and increases MKK/p38 activation. Activation of MKK3/6 is not dependent on Rac activation since dominant negative Rac does not decrease p38 activation triggered by inhibition of PI 3-kinase. Thus, cross-talk between the Akt and p38 MAPK pathways may regulate the level of cytoprotection versus apoptosis and is a new mechanism to explain the cytoprotective actions of Akt.

1 October 2002 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
ISIchiro Shiojima
Ichiro Shiojima
MYMikkael Yefremashvili
Mikkael Yefremashvili
ZLZhengyu Luo
Zhengyu Luo
YKYasuko Kureishi
Yasuko Kureishi
ATAkihiro Takahashi
Akihiro Takahashi
KWKenneth Walsh
Kenneth Walsh
Akt is a serine-threonine kinase that mediates a variety of cellular responses to external stimuli. During postnatal development, Akt signaling in the heart was up-regulated when the heart was rapidly growing and was down-regulated by caloric restriction, suggesting a role of Akt in nutrient-dependent regulation of cardiac growth. Consistent with this notion, reductions in Akt, 70-kDa S6 kinase 1, and eukaryotic initiation factor 4E-binding protein 1 phosphorylation were observed in mice with cardiac-specific deletion of insulin receptor gene, which exhibit a small heart phenotype. In contrast to wild type animals, caloric restriction in these mice had little effect on Akt phosphorylation in the heart. Furthermore, forced expression of Akt1 in these hearts restored 70-kDa S6 kinase 1 and eukaryotic initiation factor 4E-binding protein 1 phosphorylation to normal levels and rescued the small heart phenotype. Collectively, these results indicate that Akt signaling mediates insulin-dependent physiological heart growth during postnatal development and suggest a mechanism by which heart size is coordinated with overall body size as the nutritional status of the organism is varied.